Healthcare -
Biotechnology - NASDAQ - US
$ 0.91
9 %
$ 49.6 M
Market Cap
11.38
P/E
SPRO - TOTAL CURRENT LIABILITIES
Total Current Liabilities SPRO - Spero Therapeutics, Inc.
37.2 M
LAST VALUE
41.07%
2 YEAR CAGR
24.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR